Direct Conversion of Human Amniotic Cells into Endothelial Cells without Transitioning through a Pluripotent State Researchers describe a three week platform for directly converting human mid-gestation lineage-committed amniotic fluid-derived cells into a stable and expandable population of vascular endothelial cells without using pluripotency factors. [Nat Protoc] Abstract Lysophosphatidic Acid Enhances Survival of Human CD34+ Cells in Ischemic Conditions Scientists showed that lysophosphatidic acid-treated human umbilical cord blood-derived CD34+ cells cultured under hypoxic and serum-deprived conditions present 2.2-fold and 1.3-fold higher survival relatively to non-treated cells and prostaglandin E2-treated cells, respectively. [Sci Rep] Full Article Mechanical Fibrinogen-Depletion Supports Heparin-Free Mesenchymal Stem Cell Propagation in Human Platelet Lysate Investigators searched for an efficient and reproducible medium preparation method that avoids clot formation while omitting animal-derived heparin. Bone-marrow and umbilical cord derived mesenchymal stem cells were tested for surface markers by flow cytometry and for trilineage differentiation capacity. [J Transl Med] Full Article Transplantation of Mesenchymal Stem Cells in a Laryngeal Carcinoma Patient with Radiation Myelitis Researchers describe the outcome of allogeneic umbilical cord-derived mesenchymal stem cell transplantation in a patient with laryngeal carcinoma who developed radiation-induced myelitis of his spinal cord with characteristic magnetic resonance imaging changes. [Stem Cell Res Ther] Full Article Evaluation of a Cell-Banking Strategy for the Production of Clinical Grade Mesenchymal Stromal Cells from Wharton’s Jelly Factors affecting the success of the derivation process (namely, time elapsed from birth to processing and weight of fragments), and methods for establishing a two-tiered system of Master Cell Bank and Working Cell Bank of umbilical cord derived-mesenchymal stromal cells were analyzed. [Cytotherapy] Abstract A Comparison of Wharton’s Jelly and Cord Blood as a Source of Mesenchymal Stem Cells for Diabetes Cell Therapy Scientists investigated the differences between mesenchymal stem cells isolated from umbilical cord blood and Wharton’s jelly as sources of diabetes mellitus cell therapy. [Regen Med] Abstract Effects of Mesenchymal Stromal Cells on Human Myeloid Dendritic Cell Differentiation and Maturation in a Humanized Mouse Model Investigators used a humanized mouse model to study the immunomodulatory effects of human mesenchymal stromal cells on human dendritic cell immunobiology. Humanized mice were established by injection of cord blood CD34+ cells into NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice. [J Immunol Methods] Abstract |